Ovarian Cancer
Research Highlights/News
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999
» Look for consumer stories click here
2021
Research Highlights:
News:
- Wistar Scientists Identify New Therapeutic Target in Ovarian Cancer Subtype With Poor Prognosis (external link)
The Wistar Institute, September 21, 2021 - New drug class gives hope to some ovarian cancer patients (external link)
UW Medicine Newsroom, May 19, 2021 - Cancer discovery could revive failed treatments for solid tumors (external link)
EurekAlert!, April 16, 2021
2020
Press Releases:
- Department Of Defense Ovarian Cancer Research Program Anticipated Funding Opportunities For Fiscal Year 2021 (FY21)
December 9, 2020
Research Highlights:
- Developing Therapeutics In Rare Subtypes Of Ovarian Cancer
- Mentorship Is a Key Component For a Successful Ovarian Cancer Research Team
- Nanoparticles For Effective And Targeted Ovarian Cancer Treatment
- A microRNA Promotes Oncogenic Transformation Leading To Ovarian Cancer
News :
- This MicroRNA Might Help Detect, Treat Ovarian Cancer (external link)
Newswise, July 15, 2020 - Talc Powder Not Linked To Ovarian Cancer In Prospective Datasets (external link)
MEDPAGE TODAY, February 27, 2020
2019
Press Releases:
- Department Of Defense Ovarian Cancer Research Program Anticipated Funding Opportunities For Fiscal Year 2020 (FY20)
December 17, 2019
Research Highlights:
- Ovarian Cancer Academy: 10 Years of Empowering Early Career Ovarian Cancer Investigators
- Combination Immunotherapies Offer New Hope For Chemotherapy-Resistant Ovarian Cancer Patients
- A Collaborative Effort has Uncovered Novel Therapies To Treat an Aggressive Form Of Ovarian Cancer That Is Unresponsive To Standard Treatment
News :
- Scientists develop promising drug For treating ovarian, pancreatic cancers (external link)
Houston Methodist, July 26, 2019 - Out Of Many Ovarian Precancerous Lesions, One Becomes Cancer (external link)
Johns Hopkins, July 1, 2019
< h4 > 2018
Press Releases:
- Department Of Defense Ovarian Cancer Research Program Funding Opportunities For Fiscal Year 2019 (FY19)
December 20, 2018 - Department Of Defense Ovarian Cancer Research Program Anticipated Funding Opportunities For Fiscal Year 2018 (FY18)
February 13, 2018
Research Highlights
- BRCA In Ovarian Cancer: Understanding The Risk And Finding New Means of Treatment
- A Multi-Institutional Approach To Understanding the Pathology Of Ovarian Cancer
- A More Reliable Personalized Medicine-Based Approach To Test Ovarian Cancer Drugs
- Cyclin E1 As a Therapeutic Target For High-Grade Serous Ovarian Cancer
- The Impact Of the Ovarian Cancer Academy Is Long-Lasting And Far-Reaching
- Investigation Of a Novel PET Tracer To Assess PARP Inhibitor Sensitivity In Ovarian Cancer Patients
News :
- Mechanism Of Resistance To Novel Targeted Therapy For Ovarian Cancer Identified (external link)
The Wistar Institute, October 15, 2018 - Analgesic Use And Ovarian Cancer Risk (external link)
Oxford Academic, July 19, 2018 - PARP-1 May be Key To Effectiveness Of PARP Inhibitors, And Now Researchers Can Image It (external link)
Penn Medicine News, May 3, 2018 - Pushing screening Of ovarian And endometrial cancers one Step further (external link)
McGill Publications Med e-News, March 30, 2018
< h4 > 2017
Press Releases:
- Department Of Defense Ovarian Cancer Research Program Funding Opportunities For Fiscal Year 2017 January 30, 2017
Research Highlights
- Evaluation Of DNA Repair Function As a Predictor Of Response In a Clinical Trial Of PARP Inhibitor Monotherapy For Recurrent Ovarian Carcinoma
- Towards Understanding Ovarian Cancer Progression And Chemotherapy Resistance
- Chip - Based Magnetic Imager For Molecular Profiling Of Ovarian Cancer Cells
- The Clinical Development Award: Accelerating Ovarian Cancer Research into Clinical Application
- Combination Therapy Of JO-c And PEGylated Liposomal Doxorubicin/DoxilTTM In Ovarian Cancer Patients
News :
- Combination immunotherapy holds promise As improved ovarian cancer treatment (external link)
Johns Hopkins University, December 8, 2017 - 3D Cultured Cells Could Drive Precision Therapy For Cancer Treatment (external link)
Comprehensive Cancer Center – Michigan Medicine, November 16, 2017 - Diagnostic potential For a serum miRNA neural network For detection Of ovarian cancer (external link)
eLife, November 6, 2017 - Many Pelvic Tumors In Women May Have Common Origin: Fallopian Tubes (external link)
NYU Langone Health, October 31, 2017 - Expert Highlights Immunotherapy Potential In Ovarian Cancer (external link)
OncLive, October 5, 2017 - Bio - inspired approach To RNA delivery (external link)
MIT News, September 25, 2017 - Intrepid DoD Ovarian Cancer Academy Investigator Rugang Zhang Develops Alternative Therapy (external link)
The Wistar Institute, July 28, 2017 - Homologous recombination deficiency analysis predicts PARP inhibitor benefit For ovarian cancer (external link)
Healio - HemOnc Today, February 7, 2017
< h4 > 2016
Press Releases:
- Department Of Defense Ovarian Cancer Research Program Funding Opportunities For Fiscal Year 2016 January 11, 2016
Research Highlights:
- Providing Hope: Increasing Long - Term Survivorship of Ovarian Cancer Patients
- Genetic Modifiers Of Ovarian Cancer Risk In BRCA1 Mutation Carriers
- Optical Imaging Falloposcope For Minimally Invasive Ovarian Cancer Detection
- Ubiquitin - Mediated Protein Degradation Pathways For Ovarian Cancer Treatment
- Repurposing FDA-Approved Drug As a Potential Metastasis Inhibitor For Ovarian Cancer Treatment
- Therapeutic Strategies against Cyclin E1-Amplified Ovarian Cancers
Video Highlights:
News :
- Combination Therapy Improved Chemoresistance In Ovarian Cancer (external link) Wistar, November 21, 2016
2015
Press Releases:
- Department Of Defense Ovarian Cancer Research Program Funding Opportunities For Fiscal Year 2015 February 19, 2015
Research Highlights:
- Dr.Nita Maihle And Dr. Douglas Levine Lead the Ovarian Cancer Academy
- Tumor Microenvironment Gene Signatures In Ovarian Cancer
- Deciphering the Adaptive Immune Response To Ovarian Cancer
- Classifying Subtypes Of High-Grade Serous Ovarian Cancer
- The Ovarian Cancer Academy Expands
News :
-
Inhibiting DNA Methylation Causes an Interferon Response In Cancer (external link)
Cell, September 1, 2015 -
Rewriting the Book On Chemo-Resistant Cancers With a DNA Library (external link)
The University Of Kansas Cancer Center, June 2, 2015 -
AACR 2015: Olaparib And Investigational PI3K Inhibitor BKM120 Combination Active Against Ovarian And Breast Cancer Subtypes (external link)
The ASCO Post, April 28, 2015 -
New Therapeutic Strategy Discovered For Ovarian (external link)
The Wistar Institute, February 17, 2015 -
Global Deletion Of Trp53 Reverts Ovarian Tumor Phenotype Of the Germ Cell-Deficient White Spotting Variant (Wv) Mice1 (external link)
Neoplasia, January 30, 2015
2014
Press Releases:
- Department Of Defense Ovarian Cancer Research Program Funding Opportunities For Fiscal Year 2014 February 24, 2014
Research Highlights:
- Role Of Receptor Sialylation In the Ovarian Tumor Cell Phenotype
- Whole Genome Sequencing To Identify Novel Ovarian Cancer Genes
- Rethinking the Spread Of Ovarian Cancer
- The Role Of Omental Microenvironment In Ovarian Cancer Metastatic Colonization
- Nuclear Factor-Kappa B Activity In the Host-Tumor Microenvironment Of Ovarian Cancer
- Seeking To Improve Ovarian Tumor Response To Chemotherapy
News :
-
Oxygen-deprived RNA molecules lead To tumor progression (external link)
MD Anderson Cancer Center, November 4, 2014 -
MD Anderson researchers discover New route For ovarian cancer spread (external link)
MD Anderson Cancer Center, July 17, 2014 -
Researchers at Case Comprehensive Cancer Center Discover Ovarian Cancer Biomarker (external link)
Case Western Reserve University, February 21, 2014
2013
Press Releases:
- Department Of Defense Ovarian Cancer Research Program Funding Opportunities For Fiscal Year 2013 April 19, 2013
Research Highlights:
- Understanding the Molecular Effects Of BRCA mutations
- Ovarian Cancer Consortium For Research And Surveillance - Reducing the Risk
- Genetic Modifiers Of Ovarian Cancer Risk In BRCA1 Mutation Carriers
- Identifying Genetic Alterations To Guide Treatment Decisions
- Improving the Understanding Of BRCA1/2 Mutation Distributions In Ovarian Cancer
- The Outcomes Consortium Development Award: A Fresh Approach
- FY12 Teal Innovator: Building Better Medicine
- Understanding the Role Of the Immune System In the Progression Of Ovarian Cancer
- A Clinician Scientist And Advocate, Targeting Resistant Tumor-Founding Cells
News :
-
Predicting ovarian cancer by counting tumor-attacking immune cells (external link)
Fred Hutchinson Cancer Research Center, December 10, 2013 -
Ovarian Cancer Tied To Altered Estrogen Metabolism (external link)
University of Nebraska Medical Center, October 24, 2013 -
Versatile microRNAs choke off cancer blood supply, suppress metastasis (external link)
MD Anderson Cancer Center, September 24, 2013 -
Five genetic variations increase risk Of ovarian cancer (external link)
Duke Health, April 17, 2013 -
Epigenetic analysis leads To identification Of HNF1B As a subtype-specific susceptibility gene For ovarian cancer (external link)
Nature Communications, April 17, 2013 -
Identification And molecular characterization Of a New ovarian cancer susceptibility locus at 17q21.31 (external link)
Nature Communications, April 17, 2013 -
GWAS meta-analysis And replication identifies three New susceptibility loci For ovarian cancer (external link)
Nature Genetics, April 17, 2013 -
USC scientists contribute To international research On genetic risks For cancer (external link)
University of Southern California, April 16, 2013 -
Pre-clinical study identifies 'master' proto-oncogene that regulates stress-induced ovarian cancer metastasis (external link)
MD Anderson Cancer Center, February 19, 2013
Video Highlights:
2012
Press Releases:
- Department Of Defense Ovarian Cancer Research Program Funding Opportunities For Fiscal Year 2012 February 8, 2012
Research Highlights:
- Organizing the Heterogeneity In High-Grade Serous Ovarian Cancer by Mass Cytometry
- Genetic Profiling In the Australian Ovarian Cancer Study
- Premalignant Expression Signature In BRCA-1-mediated Ovarian Cancer
- Understanding Ovarian Cancer Risk Factors
- New Agents For Taxol-Resistant Ovarian Carcinoma
News :
-
Vital samples In Short supply As researchers decode chemotherapy resistance In ovarian cancer (external link)
Peter MacCallum Cancer Centre, November 20, 2012 -
Discovery leads To New hope against ovarian cancer (external link)
University of Southern California, October 8, 2012
Video Highlights:
2011
Press Releases:
Research Highlights:
- Ovarian Autoantibodies Predict Ovarian Cancer
- Structural And Functional Analysis Of CA125: Potential for Early Diagnosis And Understanding the Immune Evasion Strategies of Epithelial Ovarian Tumors
- Mumps Parotitis And Ovarian Cancer: Modern Significance of an Historic Association
- Targeting Ovarian Cancer
2010
Press Releases:
- Department Of Defense Ovarian Cancer Research Program Funding Opportunities For Fiscal Year 2010 January 21, 2010
Research Highlights:
- Use Of Novel Technologies To Identify And Investigate Molecular Markers For Ovarian Cancer Screening And Prevention - Paving the Way For the Pacific Ovarian Cancer Research Consortium
- Molecular Epidemiology Of Ovarian Cancer - Australian Ovarian Cancer Study
- The Biological Basis For Chemoprevention Of Ovarian Cancer - The International Ovarian Cancer Association Consortium
News :
-
Ovarian Cancer Advances When Genes Are Silenced (external link)
Published: December 13, 2010 -
Ovarian Cancer Survivor And Advocate: Susan Leighton (external link)
Published: April 26, 2010
2009
Press Releases:
- Department Of Defense Ovarian Cancer Research Program Funding Opportunities For Fiscal Year 2009 January 20, 2009
Research Highlights:
- Affinity - Based Serum Proteomics For Ovarian Cancer Early Diagnosis
- Resveratrol And Autophagy : Inhibiting Glucose Metabolism to Overcome Chemoresistance
- Polymorphisms, Risk, and the Chemoprevention Of Ovarian Cancer
2008
Press Releases:
- Department Of Defense Ovarian Cancer Research Program Funding Opportunities For Fiscal Year 2008 February 4, 2008
Research Highlights:
- Eliciting Autoimmunity To Ovarian Tumors In Mice by Genetic Disruption Of T Cell Tolerance Mechanisms
- Role Of Prohibitin In Ovarian Cancer Growth And Apoptotic Mechanisms
- Improving Quality Of Life For Women Confronting Ovarian Cancer
- Development And Characterization Of Animal Models
2007
Press Releases:
- Department Of Defense Ovarian Cancer Research Program Funding Opportunities For Fiscal Year 2007 March 1, 2007
Research Highlights:
- Novel Computational Biology Technologies To Identify Ovarian Cancer Biomarkers that Predict Survival
- New Animal Model To Study Ovarian Cancer
- Ovarian Granulosa Cells Show a New Mechanism For BRCA1-Induced Ovarian Tumorigenesis
- Ovarian Cancer Detection by Elevated Urinary Levels Of Bcl2
2006
Press Releases:
Research Highlights:
- A Novel Technology For Early Detection Of Serum LPAs In Ovarian Cancer
- Tipping the Balance: KLF6 Isoforms And Ovarian Cancer
- Novel bioinformatics approach To epithelial ovarian cancer marker identification
- New Molecular Technology To Identify Candidate Ovarian Cancer Oncogenes
- Liposome - Based Radiotherapies For the Treatment Of Ovarian Cancer
- Training our Nation's Finest Researchers
2005
Research Highlights:
- HOXA9, HOXA10, and HOXA11 As molecular markers And therapeutic targets In ovarian cancer
- Mutant Endostatin: Promising Antiangiogenic Therapeutic Agent for Ovarian Cancer
- Anti - Angiogenic Role Of Dendritic Cells In Ovarian Cancer
- Novel Serum Biomarkers For the Detection Of Ovarian Cancer
- Squalamine And Cisplatin : Potential Ovarian Cancer Therapeutic Agents
News :
-
Gene Link to Ovarian Cancer Discovered
(external link)
Published: March 28, 2005
2004
Press Releases:
- Ovarian Cancer Research Program For Fiscal Year 2005 September 16, 2004
- Ovarian Cancer Research Program (OCRP) Announces FY2005 (FY05) Funding Mechansims And Schedule August 25, 2004
Research Highlights:
- Development Of a Novel Vaccine With Fusions Of Dendritic And Ovarian Cancer Cells from Patients
- Blockade Of B7-H1 Improves Myeloid Dendritic Cells Mediated Antitumor Immunity In Ovarian Cancer
- The Use Of the Sindbis Vector To Combat Ovarian Cancer
- The Effects Of a Vitamin C Derivative On Ovarian Cancer
2003
Press Releases:
- Department Of Defense Ovarian Cancer Research Awards July 15, 2003
Research Highlights:
2002
Press Releases:
Research Highlights:
- New Anti - Metastatic And Anti - Angiogenic Compound For Ovarian Cancer
- Development Of a Novel Vaccine With Fusions Of Dendritic And Ovarian Cancer Cells from Patients
- Regulation Of Telomerase Activity In Ovarian Cancer
- Facilitating Decision-Making about Prophylactic Oophorectomy
2001
Press Releases:
Research Highlights:
- Chemoprevention Of Ovarian Cancer With Progestins
- Antibody Immunity To Cancer-Related Proteins As a Serologic Marker For Ovarian Cancer
2000
Press Releases:
- Department Of Defense Announces Awards Summary For FY99 Ovarian Cancer Research Program October 18, 2000
- FY00 Ovarian Cancer Research Program April 28, 2000
1999
Press Releases:
- FY98 Ovarian Cancer Research Program Awards Summary October 14, 1999
a href="#top">Top Of Page
Last updated Friday, December 3, 2021